Cargando…

PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)

Detalles Bibliográficos
Autores principales: Masarova, Lucia, Verstovsek, Srdan, Liu, Tom, Rao, Sumati, Sajeev, Guatam, Simpson, Ryan, LI, Weilong, Yang, Joseph, Gorsh, Boris, Signorovitch, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428794/
http://dx.doi.org/10.1097/01.HS9.0000975484.93174.12
_version_ 1785090555262271488
author Masarova, Lucia
Verstovsek, Srdan
Liu, Tom
Rao, Sumati
Sajeev, Guatam
Simpson, Ryan
LI, Weilong
Yang, Joseph
Gorsh, Boris
Signorovitch, James
author_facet Masarova, Lucia
Verstovsek, Srdan
Liu, Tom
Rao, Sumati
Sajeev, Guatam
Simpson, Ryan
LI, Weilong
Yang, Joseph
Gorsh, Boris
Signorovitch, James
author_sort Masarova, Lucia
collection PubMed
description
format Online
Article
Text
id pubmed-10428794
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104287942023-08-17 PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN) Masarova, Lucia Verstovsek, Srdan Liu, Tom Rao, Sumati Sajeev, Guatam Simpson, Ryan LI, Weilong Yang, Joseph Gorsh, Boris Signorovitch, James Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428794/ http://dx.doi.org/10.1097/01.HS9.0000975484.93174.12 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Masarova, Lucia
Verstovsek, Srdan
Liu, Tom
Rao, Sumati
Sajeev, Guatam
Simpson, Ryan
LI, Weilong
Yang, Joseph
Gorsh, Boris
Signorovitch, James
PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
title PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
title_full PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
title_fullStr PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
title_full_unstemmed PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
title_short PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
title_sort pb2183: transfusion-related cost offsets and time burden in patients with myelofibrosis (mf) treated with momelotinib (mmb) vs danazol (dan)
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428794/
http://dx.doi.org/10.1097/01.HS9.0000975484.93174.12
work_keys_str_mv AT masarovalucia pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT verstovseksrdan pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT liutom pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT raosumati pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT sajeevguatam pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT simpsonryan pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT liweilong pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT yangjoseph pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT gorshboris pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan
AT signorovitchjames pb2183transfusionrelatedcostoffsetsandtimeburdeninpatientswithmyelofibrosismftreatedwithmomelotinibmmbvsdanazoldan